ABSTRACT-Dysregulated release of neutrophil reactive oxygen species and proteolytic enzymes contributes to both acute and chronic inflammatory diseases. Therefore, molecular regulators of these processes are potential targets for new anti-inflammatory therapies. We have shown previously that myristoylated alanine-rich C-kinase substrate (MARCKS), a well-known actin binding protein and protein kinase C (PKC) substrate, is a key regulator of neutrophil functions. In the current study, we investigate the role of PKC-mediated MARCKS phosphorylation in neutrophil migration and adhesion in vitro. We report that treatment of human neutrophils with the δ-PKC inhibitor rottlerin significantly attenuates f-MetLeu-Phe (fMLF)-induced MARCKS phosphorylation (IC 50 =5.709 μM), adhesion (IC 50 =8.4 μM), and migration (IC 50 =6.7 μM), while α-, β-, and ζ-PKC inhibitors had no significant effect. We conclude that δ-PKC-mediated MARCKS phosphorylation is essential for human neutrophil migration and adhesion in vitro. These results implicate δ-PKC-mediated MARCKS phosphorylation as a key step in the inflammatory response of neutrophils.
As essential components of the innate immune system, neutrophils provide a first line of defense against bacterial invasion through rapid accumulation in tissue, release of proteolytic enzymes, production of reactive oxygen species, and phagocytosis of microbial pathogens. The toxic substances released by neutrophils invariably result in some degree of host tissue injury and inflammation, but this collateral damage to the host is normally limited by elimination of inciting pathogens and subsequent return to homeostasis. However, neutrophil responses that are misdirected or dysregulated can result in acute and chronic forms of inflammation that are debilitating and even life-threatening. This type of neutrophil-mediated host injury occurs in diseases such as rheumatoid arthritis, ulcerative colitis, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS) [1] . Additional medications are desperately needed to treat these acute and chronic inflammatory conditions; and neutrophils, as the cause of damaging inflammation, are a viable target for therapeutic intervention [2] . For this reason, significant research efforts have focused on discerning essential cell signaling components involved in various neutrophil functions [3] .
Protein kinase C (PKC) is one such molecular regulator known to play a significant role in neutrophil inflammatory signaling [4] . Human neutrophils express several PKCs including conventional isoforms α-and β, novel isoform δ, and atypical isoform ζ. These PKC isoforms are implicated in various neutrophil functions including adhesion, migration, oxidative burst, degranulation, and apoptosis [5, 6] . Recently, δ-PKC has emerged as a key regulator of inflammation and promising target for antiinflammatory therapy [7] . δ-PKC is activated by numerous inflammatory signals including host-derived cytokines (i.e., tumor necrosis factor alpha (TNFα) and interleukin (IL)-1) and bacterial components such as lipopolysaccharide (LPS) [6, 8, 9] . Studies targeting δ-PKC by the use of a dominant negative peptide showed this PKC isoform to be integrally involved in adherence and migration of human neutrophils in vitro [10] . Intratracheal administration of this same inhibitor peptide significantly reduced inflammatory cell infiltration and pulmonary edema following cecal ligation and puncture in rats (an animal model of ARDS) [11] . However, the molecular basis for the beneficial effects seen with δ-PKC inhibition remains uncertain.
Myristoylated alanine-rich C-kinase substrate (MARCKS) protein is another key regulator of neutrophil functions including migration, adhesion, degranulation, and respiratory burst [12] [13] [14] . As a prominent protein kinase C substrate and known actin-binding protein, MARCKS has a demonstrated role in the regulation of cellular events requiring dynamic actin reorganization [15, 16] . In most resting cells, non-phosphorylated MARCKS is localized to the inner leaflet of the plasma membrane by hydrophobic insertion of the N-terminal myristoyl-moiety and electrostatic interactions of the basic, serine-rich effector domain (ED) [17] . Membrane-bound MARCKS is believed to stabilize the cytoskeleton through actin cross-linking. Upon PKC phosphorylation of the ED, MARCKS is displaced to the cytosol and actin crosslinking is diminished, effectively relaxing the cellular cytoskeleton [18, 19] . Within the cytosol, MARCKS is dephosphorylated by specific phosphatases, reestablishing MARCKS ability to both cross-link actin and return to the plasma membrane [20] [21] [22] .
To better understand the role of MARCKS phosphorylation in neutrophil functions, we sought to determine which PKC isoforms regulate MARCKS in human neutrophils and whether or not those same isoforms were required for neutrophil migration and adhesion. To that end, we investigated PKC isotypes α, β, δ, and ζ using specific PKC isotype inhibitors Gö6976, CG53353, rottlerin, and ζ pseudosubstrate, respectively. Using subcellular fractionation, we demonstrate that of the four isotypes examined, only δ-PKC translocates from cytosol to membrane in neutrophils in response to stimulation (f-Met-Leu-Phe (fMLF) and phorbol 12-myristate 13-acetate (PMA)). Because MARCKS phosphorylation is known to occur at the plasma membrane, this pattern of δ-PKC translocation is consistent with MARCKS regulation. We further report that the δ-PKC inhibitor rottlerin inhibits MARCKS phosphorylation in human neutrophils following fMLF stimulation in a concentration-dependent manner (IC 50 = 5.709 μM). Interestingly, rottlerin pretreatment also inhibits fMLF-mediated human neutrophil migration and adhesion in a concentration-dependent manner (IC 50 of 8.385 and 7.624 μM, respectively). We conclude that δ-PKC is the primary isotype regulating MARCKS phosphorylation in human neutrophils and that δ-PKCmediated MARCKS phosphorylation is essential for neutrophil migration and adhesion. Previous research from our lab and others suggests that MARCKS and δ-PKC are both potential targets for future anti-inflammatory therapies. The results presented here shed further light on the integral relationship between these two important signaling molecules in the neutrophil's response to inflammation.
MATERIALS AND METHODS

Human Subjects
The human neutrophils utilized for this study were isolated from the peripheral blood of healthy, adult volunteers using the protocol approved by the Institutional Research Ethics Committee of North Carolina State University (IRB approval #616). Prior to donation, all participants provided written informed consent using the approved consent form.
Neutrophil Isolation
Human neutrophils were isolated from whole blood using Ficoll gradient centrifugation of dextransedimented leukocyte rich plasma, as previously described. Briefly, approximately 6 mL of plasma was layered on 5 mL of sterile, endotoxin-free Ficoll-Paque solution and spun at 600×g for 20 min. Red blood cells were removed by hypotonic lysis, and remaining neutrophils were washed once with Hank's balanced salt solution (HBSS). Cells were resuspended in HBSS with 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 8.9 mM sodium bicarbonate, 1 mM Ca 2+ , and 1 mM Mg 2+ prior to biochemical assays (HBSS ++ ) and in HBSS with 1 mM Ca 2+ , 1 mM Mg 2+ , and 2 % fetal calf serum (FCS) (chemotaxis buffer) prior to adhesion and migration assays. With this isolation method, neutrophils routinely demonstrated greater than 98 % viability as determined by trypan blue exclusion.
Fluorescence Labeling of Neutrophils
For migration and adhesion experiments, isolated neutrophils (1×10 7 /mL in HBSS) were incubated with the fluorescent dye calcein AM (Anaspec, Fremont, CA) at 2 μg/mL for 30 min at room temperature. Cells were then centrifuged at 1,000 rpm for 8 min and resuspended in chemotaxis buffer to the appropriate final experimental concentration.
Antibodies and Reagents
Ficoll-Paque Plus and Dextran T500 were from GE Healthcare (Sweden). Dimethyl sulfoxide (Me 2 SO), fMLF, PMA, Triton-X 100, pepstatin, HEPES, staurosporine, protein kinase C-ζ pseudosubstrate, and poly-L-lysine were from Sigma Chemical Co. (St. Louis, MO). Rottlerin, Gö6976, and CG53353 were from Calbiochem (Billerica, MA Resolved samples were transferred to Immobilon-P PVDF membrane (Millipore, Billerica, MA) and blocked for 1 h with 5 % nonfat dry milk in Tris-buffered saline with Tween-20 (TBS/T; 136 μM NaCl, 20 μM Tris-base (pH 7.6), and 0.1 % Tween-20 v/v) prior to overnight incubation with the 1:1,000 dilution of phospho-MARCKS or MARCKS primary antibody in 5 % BSA in TBS/T at 4°C. Membranes were washed in TBS/T and incubated with 1:4,000 dilution of anti-rabbit HRP secondary antibody (Cell Signaling Technology, Danvers, MA) in 5 % non-fat dry milk in TBS/T for 1 h with gentle agitation. Membranes were washed at room temperature in TBS/T three times for 5 min and developed using enhanced chemiluminescence and radiograph film. Films were scanned, and the density of the bands was measured with densitometric software (Scanalytics, Fairfax, VA).
Subcellular Fractionation
Subcellular fractionation assay was performed as previously described [12] . Briefly, stimulated cells were lysed by sonication in lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM DTT). The lysate was centrifuged at 800×g for 10 min to remove cell debris and nuclei. Supernatant was then centrifuged at 20,000×g for 1 h. The supernatant was collected as the cytosolic fraction, and the remaining pellet was regarded as the membrane fraction and resuspended in lysis buffer containing 1 % Triton X-10. Protein concentration was determined by Protein 660 (Pierce, Rockford, IL), and samples were diluted in 5× sample buffer and boiled for 5 min. Equal protein concentrations were loaded onto a 10 % SDS-PAGE, and Western blots were performed, as described above.
Neutrophil Chemotaxis Assay
Neutrophil chemotaxis assays were performed using the 8-μm pore size Neuro Probe ChemoTx® system as previously described [12] . Briefly, each upper well was loaded with 5×10 4 calcein-labeled neutrophils in 25 μl of chemotaxis buffer. Cells were allowed to migrate for 1 h at 37°C toward lower wells containing chemoattractants (100 nM fMLF, 100 nM LTB 4 , or 100 ng/mL IL-8) in PBS or vehicle controls (DMSO and EtOH). Following the hour migration, non-migrated cells were removed from the top of the membrane with a cell scraper. Following membrane removal, fluorescence of the bottom wells was measured (485 nm exCitation, 530 nm emission) using an fMax fluorescence plate reader (Molecular Devices). Percent migration was calculated by dividing the florescence of the experimental bottom wells by the fluorescence of bottom wells containing a known number of cells (5×10 4 cells). Treatment groups were tested in triplicate.
Neutrophil Adhesion Assay
To assess fMLF-mediated adhesion, 1.2 × 10 5 calcein-labeled neutrophils (60 μl) from the various treatment groups were aliquoted into individual wells of Immulon 2HB flat bottom 96-well plates (Thermo Fischer Scientific) previously coated with 5 % FCS in sterile PBS, as previously described [12] . The plates were then placed in a 37°C incubator while the cells settled for 10 min. Following the addition of fMLF (100 nM final concentration) or vehicle control (DMSO), the plate was floated in the 37°C water bath for 3 min. Following incubation, neutrophil adhesion was assessed using an fMax fluorescence plate reader (Molecular Devices). After an initial fluorescence reading (485 nm excitation, 530 nm emission), the plates were gently dumped in a single inverted motion; the wells were filled with 150 μl sterile PBS and another fluorescence reading was obtained. This procedure was repeated for a total of three washes to remove non-adhered cells. Fluorescence after each washing was divided by the initial fluorescence to calculate percent adhesion. The first wash that demonstrated 10 % adhesion of non-stimulated cells or less (second wash on average) was considered the final result. Treatment groups were tested in triplicate.
Statistical Analysis
Films were scanned and the density of the bands was measured with densitometric software (SigmaScan 5). Results from three identical biochemical studies were analyzed by a Student's t test with a p<0.05 considered statistically significant. Migration and adhesion data are reported as mean±SEM. Results were analyzed by one-way repeated measures ANOVA (Holm-Sidak multiple comparison testing) assuming equal variance, with p < 0.05 considered statistically significant.
RESULTS
δ-PKC Translocates from Cytosol to Plasma Membrane Upon Neutrophil Stimulation
Circulating neutrophils, initially distant from the primary site of pathogen invasion, are recruited to areas of inflammation and/or infection by a gradient of intermediate-(i.e., IL-8 and LTB 4 ) and end-stage chemoattractants (i.e., fMLF) [23] . This signaling, which occurs through transmembrane G protein-coupled chemoattractant receptors (GPCR), activates various isoforms of protein kinase C [5] . Translocation of PKC from the cytosol to the membrane compartments upon cell stimulation is indicative of intracellular PKC activation [24, 25] . To determine PKC isoform activation in human neutrophils, we performed subcellular fractionation of cell lysates following stimulation with either 100 nM fMLF or 50 ng/mL PMA. In unstimulated human neutrophils, α-, δ-, and ζ-PKC isoforms were primarily located within the cytosolic fraction, while β-PKC was partitioned to the membrane (Fig. 1) . Following stimulation, δ-PKC was the only isoform that translocated from the cytosol to the membrane. Additionally, translocation of δ-PKC was extremely rapid in response to the physiologically relevant chemoattractant fMLF (Fig. 1) . Of the four PKC isoforms investigated, δ-PKC was the only isoform that appeared activated upon stimulation of human neutrophils with either 100 nM fMLF or 50 ng/mL PMA.
MARCKS Is Transiently Phosphorylated Upon fMLF Stimulation of Primary Human Neutrophils
MARCKS plays a key role in human neutrophil migration [12] , and its bidirectional movement between the plasma membrane and the cytosol is a well-described aspect of its function [26] . Early studies by Thelen et al. show that the translocation of MARCKS between the plasma membrane and the cytosol in human neutrophils is dependent upon reversible PKC-phosphorylation of MARCKS ED [16] . Consistent with previous reports, we observed rapid phosphorylation of MARCKS following non-specific PKC activation with PMA (Fig. 2a) . However, with this receptor-independent form of activation, there was no evidence of subsequent MARCKS dephosphorylation. This finding is consistent with the nonphysiologic PKC activation seen with PMA, which is a synthetic analog of the second messenger diacylglycerol (DAG). With physiologically relevant activation using fMLF (100 nM), rapid MARCKS phosphorylation (30 s) was followed by return to baseline phosphorylation levels by 3 min (Fig. 2b) . A second phosphorylation peak was observed at 10 min. Thus, stimulation of human neutrophils with 100 nM fMLF caused a physiologically relevant pattern of MARCKS phosphorylation, which was both rapid and transient. Based on these results, we chose 30-s fMLF stimulation as the time point for maximal MARCKS phosphorylation for the remaining biochemical studies.
PKC-Mediated MARCKS Phosphorylation Is Required for Human Neutrophil Chemotaxis
Next, we sought to determine the requirement for MARCKS phosphorylation in migrating human neutrophils. As shown in Fig. 3a , pretreatment of human neutrophils with the pan-PKC inhibitor staurosporine attenuated fMLF-mediated MARCKS phosphorylation in a concentration-dependent manner, with significant inhibition seen at concentrations of 1.0 μM and greater (Fig. 3b) . From this result, we calculated that the staurosporine IC 50 for fMLF-induced MARCKS phosphorylation is 1.094 μM (Fig. 3c) . Staurosporine treatment also significantly attenuated fMLF, LTB 4 , and IL-8 induced migration of human neutrophils in a concentration-dependent manner (Fig. 3d, f) . Staurosporine inhibition of neutrophil migration for both intermediate (LTB 4 and IL-8) and end-stage Fig. 1 . δ-PKC translocates from cytosol to membrane upon neutrophil stimulation. Isolated human neutrophils were stimulated with fMLF (100 nM), PMA (50 ng/mL), or VC (DMSO) at 37°C for the indicated times. Prepared lysates were subsequently divided into membrane and cytosolic fractions using ultracentrifugation. Western blot analysis was performed to detect α-, β-, δ-, and ζ-PKC in the two fractions. Data are representative of three separate experiments using different neutrophil donors. Fig. 2 . MARCKS is rapidly phosphorylated upon stimulation of human neutrophils. Isolated human neutrophils were stimulated with a 100 nM fMLF, b 50 ng/mL PMA, or c VC (DMSO) at 37°C for times ranging from 30 to 1,800 s. Western blot analysis of lysates was performed to detect phosphorylated MARCKS (phospho-MARCKS) and total MARCKS protein (MARCKS). Data are representative of three separate experiments using different neutrophil donors. Fig. 3 . PKC-mediated MARCKS phosphorylation is required for human neutrophil chemotaxis. a-c Isolated human neutrophils were pretreated at 37°C for 30 min with indicated concentrations of the pan-PKC inhibitor staurosporine or VC (Me 2 SO) and then stimulated with 100 nM fMLF. a Representative dose response experiment (30 s fMLF stimulation). Western blot analysis of equal protein amounts from prepared lysates was performed to detect phosphorylated MARCKS (phospho-MARCKS) and total MARCKS protein (MARCKS). b Densitometry of phospho-MARCKS and total MARCKS bands was determined, and "% MARCKS phosphorylation" was calculated by dividing the phospho-MARCKS band by the total MARCKS band. Data are presented as the mean ± SE. Asterisk indicates significant (p < 0.05) difference in percent MARCKS phosphorylation compared to VC f(+). c IC 50 value (1.094 μM) was calculated by plotting percent inhibition of MARCKS phosphorylation against log 10 staurosporine concentration (μM). d-f Chemotaxis of calcein-labeled human neutrophils pretreated with indicated concentrations of staurosporine was measured using an 8-μm ChemoTx plate (Neuro Probe Inc.). d Percent neutrophil migration toward 100 nM fMLF or VC (Me 2 SO) was calculated by dividing fluorescence of migrated cells by fluorescence of total cells. Data are presented as the mean ± SE. Asterisk indicates significant (p < 0.05) difference in percent migration compared to VC f(+). e IC 50 value (0.1027 μM) was calculated by plotting percent inhibition of neutrophil migration against log 10 staurosporine concentration (μM). f Percent neutrophil migration toward 100 nM LTB 4 , 100 ng/mL IL-8, or VC (EtOH)) was calculated by dividing fluorescence of migrated cells by fluorescence of total cells. Data are presented as the mean ± SE. Asterisk indicates significant (p < 0.05) difference in percent migration of LTB 4 vs. VC ("0 μM" staurosporine). Dagger indicates significant (p < 0.05) difference in percent migration of IL-8 vs. VC ("0 μM" staurosporine). a-f All data are representative of at least three separate experiments using different neutrophil donors.
(fMLF) chemoattractants was significant at concentrations of 100 nM and greater. The staurosporine IC 50 for fMLFinduced migration is 0.1027 μM (Fig. 3e) . Our findings indicate that the staurosporine IC 50 for inhibition of migration is tenfold lower than the IC 50 calculated for the inhibition of MARCKS phosphorylation in human neutrophils. The lower inhibitory concentration for migration compared to MARCKS phosphorylation may potentially be explained by non-specific effects of pan-PKC inhibition on other signaling pathways and regulatory molecules in addition to MARCKS. It is interesting to note that in previous reports, staurosporine failed to inhibit fMLF and IL-8-induced human neutrophil adhesion and migration in vitro [27] , but these findings were reported as "data not shown." Without knowing the concentrations of staurosporine examined, it is difficult to speculate on the reasons for the difference between this previous report and our findings.
δ-PKC Regulates MARCKS Phosphorylation, Migration, and Adhesion in Human Neutrophils
Treatment of human neutrophils with the pan-PKC inhibitor staurosporine inhibited both MARCKS phosphorylation and human neutrophil migration (Fig. 3) , verifying PKC-mediated MARCKS phosphorylation is an essential event for neutrophil chemotaxis. Neutrophils express several different PKC isotypes including the conventional α-and β-PKC, the novel δ-PKC, and the atypical ζ-PKC [24] . In the next series of experiments, we utilized specific PKC isoform inhibitors to identify the PKC isoform(s) responsible for phosphorylating MARCKS in human neutrophils. Using Western blot analysis, we observed that treatment of human neutrophils with the δ-PKC inhibitor rottlerin significantly attenuated fMLF-induced MARCKS phosphorylation at concentrations of 10 μM and greater (Fig. 4a, b) . Based on these results, we determined the rottlerin IC 50 for fMLF-induced MARCKS phosphorylation of human neutrophils is 5.709 μM (Fig. 4c) . Thus, δ-PKC appears to be required for fMLFinduced MARCKS phosphorylation in human neutrophils.
Next, we investigated the effect of δ-PKC inhibition on neutrophil migration. As with fMLF-induced MARCKS phosphorylation, rottlerin concentrations of 10 μM and greater significantly inhibited both fMLFand LTB 4 -induced neutrophil chemotaxis (Fig. 4d, f) . Interestingly, significant inhibition of IL-8-mediated neutrophil chemotaxis was only achieved with rottlerin concentrations of 20 μM and greater, suggesting IL-8-mediated chemotaxis may be less dependent on δ-PKC and/or MARCKS (Fig. 4f) . The rottlerin IC 50 for fMLF-induced migration was found to be 8.385 μM (Fig. 4e) .
In order to emigrate from the vasculature into tissues, neutrophils must adhere to the endothelium [28] . We next sought to determine whether δ-PKC-mediated MARCKS phosphorylation was required for neutrophil adhesion. Consistent with our findings on MARCKS phosphorylation and migration, rottlerin concentrations of 10 μM and greater significantly inhibited fMLFinduced adhesion of human neutrophils (Fig. 4g) with an IC 50 of 7.624 μM (Fig. 4h) . We conclude from this series of experiments that δ-PKC-mediated MARCKS phosphorylation is required for human neutrophil migration and adhesion.
PKC Isoforms Alpha, Beta, and Zeta Do not Regulate MARCKS Phosphorylation in Human Neutrophils
As neutrophils express several isotypes of PKC, we next evaluated whether inhibition of α-, β-, or ζ-PKC would affect fMLF-induced MARCKS phosphorylation in human neutrophils. Based on Western blot analysis of lysates from fMLF-stimulated human neutrophils, the specific PKC isotype inhibitors Gö6976, CG53353, and PKC ζ pseudosubstrate had no effect on MARCKS phosphorylation, indicating that δ-PKC is the only PKC-isotype responsible for fMLF-induced MARCKS phosphorylation in human neutrophils.
ζ-PKC Plays a Role in Human Neutrophil Migration That Is Downstream or Independent of MARCKS Phosphorylation
Utilizing the same inhibitors as our phosphorylation study, we next investigated the requirement for α-, β-, and ζ-PKC isotypes in LTB 4 , IL-8, and fMLF-mediated human neutrophil migration. Inhibitors of α-and β-PKC (Gö6976 and CG53353, respectively) had no effect on LTB4, IL-8, or fMLF-mediated neutrophil chemotaxis (Fig. 6a, b) , but the ζ-PKC pseudosubstrate inhibitor did significantly inhibit IL-8-induced neutrophil migration at concentrations of 5 μM and greater (Fig. 6c) . These findings are consistent with previous reports implicating the atypical ζ-PKC, and not classical PKC isoforms, in the regulation of neutrophil migration and adhesion [27, 29, 30] . Based on our findings, it appears that ζ-PKC plays a role in IL-8-mediated neutrophil migration that is either independent or downstream of δ-PKC-mediated MARCKS phosphorylation.
DISCUSSION
The goal of the current study was to determine the PKC isoform(s) responsible for MARCKS phosphorylation in human neutrophils and to evaluate the requirement for MARCKS phosphorylation in neutrophil chemotaxis in vitro. Using a combination of biochemical analysis and in vitro migration and adhesion assays, we investigated four PKC isotypes known to be expressed in human neutrophils: alpha (α), beta (β), delta (δ), and zeta (ζ). We conclude that δ-PKC is the isotype responsible for MARCKS phosphorylation in fMLF-stimulated human neutrophils and that MARCKS phosphorylation is essential for in vitro neutrophil chemotaxis. These conclusions are supported by the following experimental results: (1) δ-PKC, but not other PKC isotypes, redistributed from the cytosol to the membrane following fMLF stimulation of Western blot analysis of equal protein amounts from prepared lysates was performed to detect phosphorylated MARCKS (phospho-MARCKS) and total MARCKS protein (MARCKS). b Densitometry of phospho-MARCKS and total MARCKS bands was determined, and "% MARCKS phosphorylation" was calculated by dividing the phospho-MARCKS band by the total MARCKS band. Data are presented as the mean±SE. Asterisk indicates significant (p<0.05) difference in percent MARCKS phosphorylation compared to VC f(+). c IC 50 value (5.709 μM) was calculated by plotting percent inhibition of MARCKS phosphorylation against log 10 rottlerin concentration (μM). d-f Chemotaxis of calcein-labeled human neutrophils pretreated with indicated concentrations of rottlerin was measured using an 8-μm ChemoTx plate (Neuro Probe Inc.) d Percent neutrophil migration toward 100 nM fMLF or VC (Me 2 SO) was calculated by dividing fluorescence of migrated cells by fluorescence of total cells. Data are presented as the mean±SE. Asterisk indicates significant (p<0.05) difference in percent migration compared to VC f(+). e IC 50 value (8.385 μM) was calculated by plotting percent inhibition of neutrophil migration against log 10 rottlerin concentration (μM). f Percent neutrophil migration toward 100 nM LTB 4 , 100 ng/mL IL-8, or VC (EtOH)) was calculated by dividing fluorescence of migrated cells by fluorescence of total cells. Data are presented as the mean±SE. Asterisk indicates significant (p<0.05) difference in percent migration compared to VC ("0 μM" rottlerin). g, h Adhesion of calcein-labeled human neutrophils pretreated with indicated concentrations of rottlerin using an Immulon 2HB plate coated with 5 % FCS. g Neutrophil adhesion was stimulated with 100 nM fMLF for 3 min at 37°C. Fluorescence of wells after two washes was divided by the initial fluorescence to calculate percent adhesion. Data are presented as the mean±SE. Asterisk indicates significant (p<0.05) difference in percent adhesion compared to VC f(+). h IC 50 value (7.624 μM) was calculated by plotting percent inhibition of neutrophil adhesion against log 10 rottlerin concentration (μM). a-h All data are representative of at least three separate experiments using different neutrophil donors. isolated human neutrophils (Fig. 1) . Translocation is consistent with PKC activation. (2) Pretreatment of human neutrophils with the δ-PKC inhibitor rottlerin, but not other PKC isotype inhibitors (Fig. 5) , prevented fMLF-induced MARCKS phosphorylation in a concentration-dependent manner (Fig. 4a) . (3) The range of rottlerin concentrations that blocked MARCKS phosphorylation in fMLFstimulated neutrophils also significantly attenuated fMLF-induced migration (Fig. 4d) and adhesion  (Fig. 4g) . Taken together, these findings provide strong evidence that δ-PKC is essential for neutrophil migration and adhesion. Importantly, this work also sheds new light on how δ-PKC might be regulating these important neutrophil functions-through the phosphorylation of a key substrate, MARCKS. Additional studies are needed to determine the role δ-PKC-mediated MARCKS phosphorylation plays in neutrophil functions in vivo.
The PKC family encompasses 10-15 isoforms (depending on species) that are activated by phospholipid second messengers downstream from a variety of surface receptor interactions. PKC activation is associated with translocation of the enzyme from the cytosol to various membrane compartments [25] , depending on cell type. Following activation, PKCs phosphorylate serine and threonine residues on a large number of proteins [31] . The large family of PKC enzymes is divided into three subfamilies: conventional PKCs (cPKCs), novel PKCs (nPKCs), and atypical PKCs (aPKCs). The first two subfamilies, cPKC and nPKC, have high sequence homology and are similarly activated by phorbol esters, as well as the lipidderived second messenger DAG. In addition to DAG, cPKCs also require calcium for their activation [5] . Atypical PKC isoforms share less sequence homology and do not respond to DAG, calcium, or phorbol esters but are instead activated by other membrane lipid components such as phosphatidic acid (PA) or phosphatidylinositol trisphosphates (PIP 3 ) [32, 33] .
PKC isoforms expressed in human neutrophils include two conventional isoforms (α-and β-PKC), one novel isoform (δ-PKC), and one atypical isoform (ζ-PKC) [5, 34, 35] . Several different studies have linked one or more of these PKC isoforms to a wide array of cellular processes including migration, apoptosis, adhesion, and respiratory burst [9, [36] [37] [38] [39] [40] [41] . To date, the most convincing evidence supports a role for novel (δ-PKC) and atypical (ζ-PKC) PKC isoforms in neutrophil functions including migration, adhesion, and respiratory burst. In 1996, Kent et al. demonstrated that δ-PKC is activated in fMLF-stimulated human neutrophils [24] . This is in agreement with our results, which showed δ-PKC translocation from the cytosol to the membrane following stimulation of human neutrophils with 100 nM fMLF (Fig. 1) . The study by Kent et al. also showed translocation of β-PKC from cytosolic to membrane fractions following fMLF neutrophil stimulation [24] . This finding is in contrast to the current study results (Fig. 1) . However, it is possible that this discrepancy could be explained by differences in buffer conditions. The HBSS ++ used to suspend cells in this study contains 1 mM calcium. Added calcium in the extracellular environment can lead to increased intracellular calcium [42] , and as a member of the conventional PKC subfamily, β-PKC is sensitive to calcium activation [43] . We therefore suggest that added calcium in the cell suspension media may have resulted in early β-PKC activation and subsequent accumulation within the membrane fraction, even prior to fMLF stimulation. We also saw differences in our ζ-PKC translocation results compared to a previous report by Laudanna et al. [27] . Based on our subcellular fractionation and Western blot analysis of isolated human neutrophils, ζ-PKC was primarily located in the cytosol and showed no evidence of subcellular redistribution with either fMLF or PMA stimulation. In contrast, Laudanna et al. report that ζ-PKC did translocate from the particulate fraction in resting neutrophils to the light membrane fraction in fMLF or PMAstimulated neutrophils [27] . Because we used a different method of subcellular fractionation, it is possible that there was ζ-PKC translocation that we did not detect.
Further evidence for the involvement of δ-PKC in neutrophil inflammatory functions comes from studies that utilize δ-PKC gene-deficient mice. Neutrophils from these mice show markedly reduced adhesion in vitro following fMLF or IL-8 stimulation, compared to wild-type neutrophils [44] . In addition, neutrophil adhesion, migration, superoxide generation, and degranulation are reduced in δ-PKC null mice in vivo [44] . Additional in vivo studies have utilized a δ-PKC-specific inhibitor peptide (TAT-PKCδ) to examine the role of this PKC isotype in neutrophil-mediated lung injury. Intratracheal instillation of this dominant negative peptide significantly attenuates neutrophil infiltration, chemokine expression, and pulmonary edema following cecal ligation and puncture-induced sepsis in rats [11] . From these studies, it is clear that δ-PKC is activated during sepsis-induced pulmonary inflammation [11] and that δ-PKC plays an important role in neutrophil recruitment to the inflamed lung [10] , but the molecular mechanisms of this regulation remain uncertain. Like δ-PKC, previous study results have also implicated MARCKS as an important regulator of various neutrophil functions. In 2006, Takashi et al. demonstrated that inhibition of MARCKS, using a MARCKS-specific inhibitor peptide known as MANS, caused a decrease in PMAmediated neutrophil degranulation in vitro [13] . MANSmediated MARCKS inhibition also abrogated ozone- [45] and elastase- [46] induced airway neutrophilia in mice in vivo. Subsequent studies by our laboratory utilized the MANS peptide to show that MARCKS function is essential for in vitro neutrophil functions including migration, adhesion, and respiratory burst [12] . Most recently, work by Nordone et al. [47] showed that MANS treatment of LPS-stimulated canine neutrophils in vitro significantly attenuates production of inflammatory cytokines including IL-8 and TNFα. Interestingly, a MARCKS inhibitor peptide known as MANS, which stands for myristoylated aminoterminal sequence, has no known effect on MARCKS phosphorylation; but based on studies in several different cell types, MARCKS phosphorylation is a key step in regulating a variety of cellular events including spreading [26, 48, 49] , adhesion [50, 51] , motility [52] [53] [54] , neurosecretion [55] , membrane trafficking [41, [56] [57] [58] , and tumorigenesis [59, 60] . Also, the PKC isotype responsible for MARCKS phosphorylation varies depending on cell type [41, [61] [62] [63] [64] [65] [66] . In this study, we hypothesized that MARCKS phosphorylation in human neutrophils would be regulated by a specific PKC isotype. We further hypothesized that MARCKS phosphorylation would be required for neutrophil functions (i.e., migration and adhesion) in vitro. To our knowledge, this is the first study to concurrently investigate PKC activation and MARCKS phosphorylation in human neutrophil functions in vitro.
Using rottlerin to inhibit δ-PKC activation, we observed concentration-dependent inhibition of MARCKS phosphorylation (Fig. 4a), migration (Fig. 4d) , and adhesion ( Fig. 4g ) in fMLF-stimulated human neutrophils with markedly similar IC 50 concentrations of 5.074 μM (Fig. 4c) , 8.385 μM (Fig. 4e) , and 7.624 μM (Fig. 4h) , respectively. Inhibitors of α-, β-, and ζ-PKC had no effect on MARCKS phosphorylation (Fig. 5a-c) . Furthermore, we demonstrate that LTB 4 and IL-8 induced migration are also dependent on δ-PKC-mediated MARCKS phosphorylation (Fig. 4f) . It is worth noting, however, that significant inhibition of IL-8 induced migration requires a higher rottlerin concentration (i.e., 20 μM) than inhibition of migration induced by fMLF or LTB 4 (i.e., 10 μM). This difference in inhibitory effect may reflect variability in the importance of certain PKC isotypes depending on the signal of activation.
One perceived drawback of inhibitor studies, like the one reported here, is the potential for "off-target" effects of inhibitors. In the current report, we utilized rottlerin as an inhibitor of δ-PKC. Previous reports identify rottlerin as a specific δ-PKC inhibitor with an IC 50 of 3.0 to 6.0 μM. Rottlerin also reportedly inhibits conventional (IC 50 for α-and β-PKC=30-42 μM), as well as atypical (IC 50 for ζ-PKC=80-100 μM) PKC isoforms [67, 68] . Based on these reports, rottlerin-mediated δ-PKC inhibition is five to ten times more potent than conventional PKC inhibition and almost 30 times more potent than atypical PKC inhibition. But critics of rottlerin claim that this inhibitor causes nonspecific δ-PKC inhibition due to mitochondrial uncoupling and reduced levels of cellular ATP [69] . However, a recent study using dermal fibroblasts shows that rottlerin-induced upregulation of mitochondrial uncoupling agents is limited. Moreover, this study showed agreement in specificity among three methods of δ-PKC inhibition (i.e., δ-PKC siRNA knockdown, δ-PKC inhibitory peptide, and rottlerin treatment) based on RNA and microarray analysis [70] . While we feel there is ample evidence to support the use of rottlerin as a specific δ-PKC inhibitor [71] [72] [73] , we plan to further investigate MARCKS phosphorylation in neutrophils with more therapeutically relevant methods of δ-PKC inhibition in vivo.
Another key finding of the current study was the observation that ζ-PKC inhibition had no effect on MARCKS phosphorylation in human neutrophils (Fig. 5c ) but did significantly inhibit IL-8-mediated chemotaxis (Fig. 6c) . We also observed a downward trend of fMLF and LTB4-induced migration with ζ-PKC inhibition, but this was not significant. Our findings are in agreement with previous reports that ζ-PKC is a key regulator of motility in hematopoietic cells [29] . Several studies have shown that treatment of isolated human neutrophils with ζ-PKC pseudosubstrate inhibitor peptide significantly attenuates IL-8 induced adhesion [27] . Specifically, results from Chakrabarti et al. point to a role for ζ-PKC in the regulation of the β2-integrin CD11b (also known as MAC-1) affinity and avidity [74] . We take great interest in the finding that ζ-PKC attenuates IL-8-mediated neutrophil chemotaxis in vitro with no apparent effect on MARCKS phosphorylation and plan to perform followup investigations.
As presented here, our study results show that δ-PKC activation is essential for MARCKS phosphorylation in human neutrophils and that inhibition of MARCKS phosphorylation correlates with a decrease in neutrophil migration and adhesion. Our results also show that ζ-PKC, which had no observed effect on MARCKS phosphorylation, plays a key role in neutrophil migration, at least toward the intermediate chemoattractant IL-8. Based on the known Fig. 5 . PKC isoforms alpha, beta, and zeta do not regulate MARCKS phosphorylation in human neutrophils. a-c Isolated human neutrophils were pretreated at 37°C with indicated concentrations of a α-, b β-, and c ζ-PKC inhibitors or vehicle control (Me 2 SO) and then stimulated with 100 nM fMLF. Western blot analysis of equal protein amounts from prepared lysates was performed to detect phosphorylated MARCKS (phospho-MARCKS) and total MARCKS protein (MARCKS). Data are representative of at least three separate experiments using different neutrophil donors. Fig. 6 . ζ-PKC plays a role in IL-8-mediated chemotaxis of human neutrophils. a-c Chemotaxis of calcein-labeled human neutrophils pretreated with indicated concentrations of a α-, b β-, and c ζ-PKC inhibitors or vehicle control (Me 2 SO) was measured using an 8-μm ChemoTx plate (Neuro Probe Inc.). Percent neutrophil migration toward 100 nM fMLF, 100 nM LTB 4 , 100 ng/mL IL-8, or VC was calculated by dividing fluorescence of migrated cells by fluorescence of total cells and is presented as the mean ± SE. Dagger indicates significant (p < 0.05) difference in percent migration of IL-8 vs. VC ("0 μM" staurosporine). Data are representative of at least three separate experiments using different neutrophil donors. physiology of the signaling components involved we propose the following narrative to explain our observations. In neutrophils, δ-PKC (a novel PKC isotype) is activated downstream of GPCR signaling by the secondary messenger DAG [75] . Activation of δ-PKC involves translocation to the plasma membrane [24] , where the substrate MARCKS is localized in resting cells [16] . δ-PKC phosphorylation of MARCKS ED disrupts the electrostatic interaction with the plasma membrane and displaces MARCKS to the cytosol [26, 76, 77] . This PKC-mediated regulation of MARCKS has at least two significant effects on the cell. (1) MARCKS phosphorylation decreases actin cross-linking and allows for dynamic actin reorganization [17-19, 22, 26, 40, 49, 51, 58, 78] . (2) MARCKS phosphorylation displaces it from the membrane and effectively liberates pools of phosphoinositides (i.e., PIP 2 and PIP 3 ) to be involved in additional cell signaling [51, 52, 66, [78] [79] [80] [81] . We propose that an increase in unsequestered PIP 2 /PIP 3 , as occurs with MARCKS phosphorylation, may facilitate the activation of ζ-PKC [82] , potentially placing the role of this atypical PKC isotype downstream of δ-PKC-mediated MARCKS phosphorylation.
CONCLUSIONS
We conclude that novel isotype δ-PKC is responsible for MARCKS phosphorylation in human neutrophils following fMLF stimulation and that MARCKS phosphorylation is essential for neutrophil migration and adhesion. Additionally, we find that ζ-PKC, which is an essential signaling component in IL-8-induced neutrophil migration, may be activated downstream of δ-PKC-mediated MARCKS phosphorylation. Ultimately, our goal is to better understand the complex molecular interactions regulating neutrophil migration and adhesion in an effort to identify potential targets for new anti-inflammatory therapies. We submit that the current report contributes valuable information regarding two key components of neutrophil inflammatory functions, δ-PKC and MARCKS. To our knowledge, this study is the first report suggesting these two proteins may be integrally linked in the regulation of neutrophil migration. We plan to validate the importance of these in vitro findings with additional studies in vivo.
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